Michael Mingzhao Xing Lab

  • Investigators in the Michael Mingzhao Xing Lab study the cellular and molecular mechanisms of thyroid cancer, including its genetic and epigenetic alterations and related cellular behaviors. We are particularly interested in exploring cellular and molecular derangements associated with the MAP kinase and PI3K/Akt pathways as a fundamental mechanism in thyroid tumorigenesis. The clinical translation of research findings is an important focus for us. Examples include the team’s demonstrations of the prognostic value of the BRAF mutation for risk stratification of thyroid cancer, as well as its preoperative value when tested on thyroid fine-needle biopsy specimens.

    Research Areas: thyroid cancer, molecular genetics, epigenetics, genomics

    Lab Website

    Principal Investigator

    Michael Xing, M.D., Ph.D.

    Department

    Medicine